Search research articles
Contact Us
Filters
Showing results (281-290 of 457) with videos related to
Page
of 46
Sort By:
Blood Cancer Journal
|
July 26, 2022
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
Hassan B Alkhateeb, Razan Mohty, Patricia Greipp, et al.
American Journal of Hematology
|
November 23, 2017
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia
Roland B Walter, Laura C Michaelis, Megan Othus, et al.
American Journal of Hematology
|
February 12, 2024
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers
Yasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, et al.
JCI Insight
|
July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Marlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
British Journal of Haematology
|
October 26, 2021
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia
Zaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, et al.
American Journal of Hematology
|
April 25, 2017
High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia
Aishwarya Ravindran, Janani Sankaran, Eapen K Jacob, et al.
Blood
|
December 1, 2007
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H Goldstone, Susan M Richards, Hillard M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results
Matthew J Wieduwilt, Jun Yin, Oudom Kour, et al.
Blood Cancer Journal
|
March 5, 2021
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
Maansi Joshi, Joselle Cook, Kristen McCullough, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Page
of 46
Search research articles
Search
Showing results (281-290 of 457) with videos related to
Sort By:
Page
of 46
Blood Cancer Journal
|
July 26, 2022
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
Hassan B Alkhateeb, Razan Mohty, Patricia Greipp, et al.
American Journal of Hematology
|
November 23, 2017
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia
Roland B Walter, Laura C Michaelis, Megan Othus, et al.
American Journal of Hematology
|
February 12, 2024
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers
Yasmin Abaza, Eric S Winer, Guru Subramanian Guru Murthy, et al.
JCI Insight
|
July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
Marlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
British Journal of Haematology
|
October 26, 2021
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia
Zaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, et al.
American Journal of Hematology
|
April 25, 2017
High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia
Aishwarya Ravindran, Janani Sankaran, Eapen K Jacob, et al.
Blood
|
December 1, 2007
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H Goldstone, Susan M Richards, Hillard M Lazarus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results
Matthew J Wieduwilt, Jun Yin, Oudom Kour, et al.
Blood Cancer Journal
|
March 5, 2021
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
Maansi Joshi, Joselle Cook, Kristen McCullough, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
Page
of 46